AMPA Receptor Trafficking in Natural and Pathological Aging

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) enable most excitatory transmission in the brain and are crucial for mediating basal synaptic strength and plasticity. Because of the importance of their function, AMPAR dynamics, activity and subunit composition undergo a tight...

Full description

Bibliographic Details
Main Author: Sandra Jurado
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-01-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fnmol.2017.00446/full
id doaj-b7760c015e8d4a20813322055ed5ba03
record_format Article
spelling doaj-b7760c015e8d4a20813322055ed5ba032020-11-24T23:10:26ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992018-01-011010.3389/fnmol.2017.00446320787AMPA Receptor Trafficking in Natural and Pathological AgingSandra Jurado0nstituto de Neurociencias CSIC-UMH, San Juan de Alicante, Spainα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) enable most excitatory transmission in the brain and are crucial for mediating basal synaptic strength and plasticity. Because of the importance of their function, AMPAR dynamics, activity and subunit composition undergo a tight regulation which begins as early as prenatal development and continues through adulthood. Accumulating evidence suggests that the precise regulatory mechanisms involved in orchestrating AMPAR trafficking are challenged in the aging brain. In turn dysregulation of AMPARs can be linked to most neurological and neurodegenerative disorders. Understanding the mechanisms that govern AMPAR signaling during natural and pathological cognitive decline will guide the efforts to develop most effective ways to tackle neurodegenerative diseases which are one of the primary burdens afflicting an increasingly aging population. In this review, I provide a brief overview of the molecular mechanisms involved in AMPAR trafficking highlighting what is currently known about how these processes change with age and disease. As a particularly well-studied example of AMPAR dysfunction in pathological aging I focus in Alzheimer’s disease (AD) with special emphasis in how the production of neurofibrillary tangles (NFTs) and amyloid-β plaques may contribute to disruption in AMPAR function.http://journal.frontiersin.org/article/10.3389/fnmol.2017.00446/fullAMPAR receptorsagingneurodegenerative diseasesAlzheimer’s diseasesynaptic transmission
collection DOAJ
language English
format Article
sources DOAJ
author Sandra Jurado
spellingShingle Sandra Jurado
AMPA Receptor Trafficking in Natural and Pathological Aging
Frontiers in Molecular Neuroscience
AMPAR receptors
aging
neurodegenerative diseases
Alzheimer’s disease
synaptic transmission
author_facet Sandra Jurado
author_sort Sandra Jurado
title AMPA Receptor Trafficking in Natural and Pathological Aging
title_short AMPA Receptor Trafficking in Natural and Pathological Aging
title_full AMPA Receptor Trafficking in Natural and Pathological Aging
title_fullStr AMPA Receptor Trafficking in Natural and Pathological Aging
title_full_unstemmed AMPA Receptor Trafficking in Natural and Pathological Aging
title_sort ampa receptor trafficking in natural and pathological aging
publisher Frontiers Media S.A.
series Frontiers in Molecular Neuroscience
issn 1662-5099
publishDate 2018-01-01
description α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) enable most excitatory transmission in the brain and are crucial for mediating basal synaptic strength and plasticity. Because of the importance of their function, AMPAR dynamics, activity and subunit composition undergo a tight regulation which begins as early as prenatal development and continues through adulthood. Accumulating evidence suggests that the precise regulatory mechanisms involved in orchestrating AMPAR trafficking are challenged in the aging brain. In turn dysregulation of AMPARs can be linked to most neurological and neurodegenerative disorders. Understanding the mechanisms that govern AMPAR signaling during natural and pathological cognitive decline will guide the efforts to develop most effective ways to tackle neurodegenerative diseases which are one of the primary burdens afflicting an increasingly aging population. In this review, I provide a brief overview of the molecular mechanisms involved in AMPAR trafficking highlighting what is currently known about how these processes change with age and disease. As a particularly well-studied example of AMPAR dysfunction in pathological aging I focus in Alzheimer’s disease (AD) with special emphasis in how the production of neurofibrillary tangles (NFTs) and amyloid-β plaques may contribute to disruption in AMPAR function.
topic AMPAR receptors
aging
neurodegenerative diseases
Alzheimer’s disease
synaptic transmission
url http://journal.frontiersin.org/article/10.3389/fnmol.2017.00446/full
work_keys_str_mv AT sandrajurado ampareceptortraffickinginnaturalandpathologicalaging
_version_ 1725607220462223360